IP Library Granted Patent US 8,557,259
Granted Patent B2
US 8,557,259 · App. 11/399,368 · Granted Oct 15, 2013

Liquid preparation

Inventors: Norio Goto (Honjo, JP); Koichi Shibusawa (Honjo, JP)
Assignee: Eisai R&D Management Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,557,259
App. No.
11/399,368
Granted
Oct 15, 2013
Kind
B2
Abstract

It is an object of the present invention to provide a liquid preparation which excels in stability with no occurrence of precipitates and lees even after long storage. The liquid preparation contains a lipophilic material, a sucrose fatty acid ester, a polyoxyethylene hydrogenated castor oil, a polyglycerin fatty acid ester, a polyol and water. Also provided are a pharmaceutical preparation, cosmetic preparation, food and drink which contain the liquid preparation.

Claims (16)

1. A liquid preparation comprising:

a lipophilic material comprising at least one vitamin E;

a sucrose fatty acid ester which is at least one member selected from the group consisting of sucrose stearate, sucrose palmitate, sucrose myristate, sucrose oleate, sucrose laurate, sucrose behenate, and sucrose erucate;

30% by mass to 100% by mass, relative to said lipophilic material, of a polyoxyethylene hydrogenated castor oil;

10% by mass to 200% by mass, relative to said lipophilic material, of a polyglycerin fatty acid ester;

30% by mass to 80% by mass, relative to the total amount of the liquid preparation, of glycerin; and

water.

2. The liquid preparation according to claim 1 , wherein the vitamin E is selected from the group consisting of α-tocopherol, β-tocopherol, γ-tocopherol, δ-tocopherol, α-tocotrienol, β-tocotrienol, γ-tocotrienol, δ-tocotrienol and organic acid salts thereof.

3. The liquid preparation according to claim 2 , wherein the organic acid salt is at least one selected from the group consisting of acetate, nicotinate and succinate.

4. The liquid preparation according to claim 1 , wherein the content of the sucrose fatty acid ester relative to lipophilic material is 0.3% by mass to 4% by mass.

5. The liquid preparation according to claim 1 , wherein the addition mole number of ethylene oxide in the polyoxyethylene hydrogenated castor oil is 30 to 80.

6. The liquid preparation according to claim 1 , wherein the polyglycerin moiety in the polyglycerin fatty acid ester has a condensation degree of 2 to 10.

7. The liquid preparation according to claim 1 , wherein the carbon number of the polyglycerin fatty acid ester is 10 to 22.

8. A method of manufacturing a liquid preparation comprising: mixing of at least one vitamin E, a sucrose fatty acid ester, a polyoxyethylene hydrogenated castor oil, a polyglycerin fatty acid ester, glycerin, and water, wherein the liquid preparation comprises: a lipophilic material comprising at least one vitamin E; a sucrose fatty acid ester which is at least one member selected from the group consisting of sucrose stearate, sucrose palmitate, sucrose myristate, sucrose oleate, sucrose laurate, sucrose behenate, and sucrose erucate; 30% by mass to 100% by mass, relative to said lipophilic material, of a polyoxyethylene hydrogenated castor oil; 10% by mass to 200% by mass, relative to said lipophilic material, of a polyglycerin fatty acid ester; 30% by mass to 80% by mass, relative to the total amount of the liquid preparation, of glycerin; and water.

9. A pharmaceutical preparation, cosmetic preparation, food, or drink comprising: a liquid preparation, wherein the liquid preparation comprises: a lipophilic material comprising at least one vitamin E; a sucrose fatty acid ester which is at least one member selected from the group consisting of sucrose stearate, sucrose palmitate, sucrose myristate, sucrose oleate, sucrose laurate, sucrose behenate, and sucrose erucate; 30% by mass to 100% by mass, relative to said lipophilic material, of a polyoxyethylene hydrogenated castor oil; 10% by mass to 200% by mass, relative to said lipophilic material, of a polyglycerin fatty acid ester; 30% by mass to 80% by mass, relative to the total amount of the liquid preparation, of glycerin; and water.

10. The pharmaceutical preparation, cosmetic preparation, food, or drink according to claim 9 , wherein the liquid preparation is diluted with at least one member selected from the group consisting of water, buffer fluid and aqueous solution.

Assignments (4)
MERGER Recorded Feb 1, 2018
From: EISAI FOOD & CHEMICAL CO., LTD.
To: MITSUBISHI-CHEMICAL FOODS CORPORATION
Reel/Frame 045212/0962 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2016
From: EISAI R&D MANAGEMENT CO., LTD.
To: EISAI FOOD & CHEMICAL CO., LTD.
Reel/Frame 037755/0240 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 24, 2007
From: EISAI CO., LTD.
To: EISAI R&D MANAGEMENT CO., LTD.
Reel/Frame 019604/0629 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2006
From: GOTO, NORIO; SHIBUSAWA, KOICHI
To: EISAI CO., LTD.
Reel/Frame 017770/0828 →
Priority Claims (1)
JP 2003-352491 · Oct 10, 2003 · national
Continuity (2)
Continuation PCTJP2004014646 · Oct 5, 2004
Related Publication 20060189662A1 · Aug 24, 2006